Tyler Wish is the CEO and Co-Founder of Sequence Bio, a data-driven biotechnology company in Newfoundland and Labrador leading a 100,000 person genome project. A trained epidemiologist, Tyler has a background in large-scale population-based research, human genetics and drug discovery. Tyler serves as a Canadian Innovation Leader as part of the Government of Canada and Minister’s Navdeep Bains’ innovation agenda and sits on BIOTECanada’s Emerging Companies Advisory Board. Dr. Wish completed a B.Sc (Chemistry) from the University of Victoria and a PhD (Medicine) from Memorial University of Newfoundland where he investigated the clinical and molecular epidemiology of inherited cancer syndromes.